SG

Sonia Gupta

Director Director DIN 06998420
DIN 06998420 First appointment Sep 2014 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Sep 2014
Shareholding value β€’β€’β€’β€’ Premium profile

About Sonia Gupta

Data last updated:

Sonia Gupta was a Director at Brooks Laboratories Limited (2014–2024) and Designated Partner at Welworth Innovations Llp (from 2023). The companies operate in Pharma.

DIN 06998420
Primary Designation Director
Industry Pharma
First Appointment 29 Sep 2014
Oldest Company Age 3 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Brooks Laboratories Limited L24232HP2002PLC000267
Director29 Sep 20142002₹83.44 Cr (FY 2025)Active
Designated Partner24 Apr 20232023Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Welworth Innovations Llp
Brooks Laboratories Limited
Premium access

Shareholding and investment profile for Sonia Gupta

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sonia Gupta

Sonia Gupta was first appointed on 29 Sep 2014 as Director at Brooks Laboratories Limited. The most recent appointment on record is 24 Apr 2023 at Welworth Innovations Llp.

Sonia Gupta held 2 earlier board appointments: Brooks Laboratories Limited (Director, 29 Sep 2014 to 29 Sep 2024); Welworth Innovations Llp (Designated Partner, from 24 Apr 2023).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available